210 related articles for article (PubMed ID: 11838657)
1. Sumatriptan use in patients with migraine.
Canario JR; Shenenberger DW
Mayo Clin Proc; 2002 Feb; 77(2):201. PubMed ID: 11838657
[No Abstract] [Full Text] [Related]
2. [Migraine: sumatriptan].
Yamada K; Naritomi H
Nihon Naika Gakkai Zasshi; 2001 Apr; 90(4):607-12. PubMed ID: 11391907
[No Abstract] [Full Text] [Related]
3. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
Scheen AJ
Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
[No Abstract] [Full Text] [Related]
4. Tolerability of sumatriptan: clinical trials and postmarketing experience.
Allen C; Dayno J
Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
[No Abstract] [Full Text] [Related]
5. Triptans and migraine.
Bateman DN
Lancet; 2000 Mar; 355(9207):860-1. PubMed ID: 10752697
[No Abstract] [Full Text] [Related]
6. Looking forward: the expanding utility of sumatriptan and naratriptan.
Cady R
Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
[No Abstract] [Full Text] [Related]
7. Imigran: Ten years of improving the lives of migraine patients. Rome, 24 March 2000. Proceedings of a conference.
Cephalalgia; 2001; 21 Suppl 1():1-41. PubMed ID: 11904860
[No Abstract] [Full Text] [Related]
8. Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study.
Putnam GP; O'Quinn S; Bolden-Watson CP; Davis RL; Gutterman DL; Fox AW
Cephalalgia; 1999 Sep; 19(7):668-75. PubMed ID: 10524661
[TBL] [Abstract][Full Text] [Related]
9. Building on the sumatriptan experience: the development of naratriptan.
Connor HE
Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
[No Abstract] [Full Text] [Related]
10. Assessing patient preference in migraine treatment.
Dahlöf C
Cephalalgia; 2001 Oct; 21(8):791-5. PubMed ID: 11737002
[No Abstract] [Full Text] [Related]
11. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
Deleu D; Hanssens Y
Neurology; 2003 Apr; 60(7):1221-2; author reply 1221-2. PubMed ID: 12682349
[No Abstract] [Full Text] [Related]
12. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
Mathew NT
Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397
[TBL] [Abstract][Full Text] [Related]
14. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
Géraud G; Valette C
Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
[TBL] [Abstract][Full Text] [Related]
15. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
Goldstein D
Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
[No Abstract] [Full Text] [Related]
16. Sumatriptan: efficacy and contribution to migraine mechanisms.
Pearce JM
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
[No Abstract] [Full Text] [Related]
17. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
[TBL] [Abstract][Full Text] [Related]
18. How to assess patient preference of migraine treatments.
Dahlöf C
Cephalalgia; 1999 Jul; 19 Suppl 24():2-5; discussion 5-6. PubMed ID: 10526675
[No Abstract] [Full Text] [Related]
19. A 27-year-old woman with migraine headaches.
Welch KM
JAMA; 1997 Jul 23-30; 278(4):322-8. PubMed ID: 9228439
[No Abstract] [Full Text] [Related]
20. Effects of medication use on health state in postictal migraineurs.
Mulder EJ; Passchier J; Linssen WH; de Geus EJ
Headache; 2001 Sep; 41(8):782-91. PubMed ID: 11576203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
